New research has revealed that two therapies may slow the progression of diabetic retinopathy in people suffering from type 2 diabetes.
Results from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study, supported by the National Institutes of Health, indicate that studying the back of the eye may be a potential indicator of what is happening in other parts of the body.
Emily Chew, chair of the Eye Study, said it indicates that intensive glycemic control and fibrate treatment added to statin therapy separately reduce the progression of diabetic retinopathy.
"The main ACCORD findings showed that fibrate treatment added to statin therapy is safe for patients like those involved in the study. However, intensive blood sugar control to near normal glucose levels increased the risk of death and severe low blood sugar," she explained.
Meanwhile, researchers at the University of Massachusetts Medical School have claimed that valproic acid, which reduces seizures, treats migraines and manages bipolar disorder, appears to have an effect in halting vision loss in patients with retinitis pigmentosa and also improves field of vision in many patients.
by Martin Burns